SANDOSTATIN LAR (Octreotide)-30mg

Sandostatin® (Octreotide Acetate), a hormone drug, suppresses the secretion of growth hormone (GH), and in many cases suppresses insulin-like growth hormone-1 (IGF-1) (somatomedin C).

Classified as a somatostatin analog is indicated for long-term treatment of severe diarrhea and flushing episodes associated with metastatic carcinoid tumors such as carcinoid, pancreatic islet cell tumors, gastrinoma, or vasoactive intestinal peptide-secreting tumors (VIPomas) and long-term treatment of the profuse watery diarrhea associated with VIP-secreting tumors in patients in whom initial treatment with immediate-release. It is also used to treat acromegaly when the body produces too much growth hormone, and the hands, feet, face, or head grow too large.

Enquiry Now

Additional information

Trade Name

SANDOSTATIN LAR

Generic Name

Octreotide

Manufacturer

Novartis India Ltd

Drug Type

Oncology

Indication

pancreatic cancer

Doasage Form

Injectible

Packaging

1 X 1 prefilled syringe of 2ml